Skip to main contentAI and Advanced
/
SAGILITY · NSEBSE SENSEX77,537.72+0.82%BSE |
NIFTY 5024,231.85+0.64%NSE |
NIFTY BANK57,495.9+0.45%NSE |
NIFTY IT30,673.05+0.79%NSE |
NIFTY AUTO29,301.75+0.40%NSE |
NIFTY FMCG47,863.25+0.82%NSE |
NIFTY PHARMA26,416+0.39%NSE |
NIFTY 50023,512.95+0.54%NSE |
SA
NSE · Equity shares · Business Services0.06 · 0.14%
Sagility SAGILITY
NSE:INR 42.56
BSE:INR 43.84
Data quality and coveragePrice, company fundamentals and optional research feeds are tracked separately.
Headline priceLast market snapshot
Company fundamentalsStale · last-known data
Research sections9 of 9 availableMissing source values remain unavailable, never zero-filled.
AI analysis and Advanced tools for SAGILITY
Analysis, reports, chat and Advanced access use the same ShareKeyX account. The backend remains authoritative for roles, subscriptions, credits and permissions.
Snapshot
Price and key statistics
Reported and computed values remain separate; missing values are not converted to zero.
Previous closeINR 42.5
Day rangeINR 41.97 — INR 42.98
52-week rangeINR 35.83 — INR 57.89
Volume1.85 Cr
Market cap20,494.92
P/E18.62
Fundamental highlightsReported values unless marked as computed
Revenue (INR Cr)7,192.85
Net Income (INR Cr)924.77
P/E Ratio18.62
EPS2.03
Research path: Interpret Sagility's snapshot alongside the wider market dashboard, the financial-statement research guide and the valuation-ratios field guide.
Validated OHLC
Interactive price chart
Crosshair, OHLCV tooltip, indicators, volume, zoom and pan use the same candle API as the advanced workspace.
SAGILITYSagility1d · INR · NSE
Loading validated candles…
Auditable calculations
Daily technical summary
Calculated from validated daily candles. Descriptive research only.
Calculating technicals…
Indicators describe price behaviour and volatility; they are not a BUY, NEUTRAL or SELL recommendation.
Company reporting
Financial statements
IND AS · INR crore
| Metric | 2026 | 2025 | 2024 |
|---|---|---|---|
| Total Liabilities Shareholders' Equity | 12,601.08 | 11,050.66 | 10,664.2 |
| Accumulated Depreciation Total | -823.44 | -576.9 | -442.44 |
| Cash Equivalents | 190.63 | 259.08 | 41.69 |
| Other Liabilities Total | 242.26 | 174.16 | 161.86 |
| Accrued Expenses | 510.33 | 449.87 | 363.22 |
| Long Term Debt | 0 | 567.04 | 1,664.7 |
| Common Stock Total | 4,679.27 | 4,679.27 | 4,285.28 |
| Other Equity Total | 824.4 | 412.56 | 302.4 |
| Other Current Assets Total | 24.66 | 35.51 | 23.68 |
| Prepaid Expenses | 93.67 | 79.48 | 75.78 |
| Total Assets | 12,601.08 | 11,050.66 | 10,664.2 |
| Current Portof LT Debt/Capital Leases | 718.89 | 363.55 | 375.84 |
| Additional Paid-In Capital | 5,052.37 | 5,052.37 | 4,324.1 |
| Cash | 167.28 | 84.67 | 302.44 |
| Total Equity | 9,659.1 | 8,336.05 | 6,443.13 |
| Retained Earnings(Accumulated Deficit) | -896.95 | -1,808.16 | -2,468.66 |
| Total Common Shares Outstanding | 468.13 | 468.13 | 468.13 |
| Property/Plant/Equipment Total-Gross | 1,772.61 | 1,498.99 | 1,397.83 |
| Tangible Book Valueper Share Common Eq | 2.59 | 0.56 | -2.72 |
| Goodwill Net | 6,405.15 | 6,039.01 | 5,709.59 |
| Total Liabilities | 2,941.98 | 2,714.61 | 4,221.07 |
| Total Debt | 1,100 | 1,387.02 | 2,511.89 |
| Short Term Investments | 545.87 | Not available | Not available |
| Cashand Short Term Investments | 903.79 | 343.76 | 344.13 |
| Total Receivables Net | 1,908.42 | 1,351.23 | 1,267.95 |
| Notes Payable/Short Term Debt | 0 | 0 | 0 |
| Deferred Income Tax | 421.11 | 427.88 | 471.04 |
| Accounts Receivable-Trade Net | 1,841.71 | 1,287.79 | 1,181.34 |
| Property/Plant/Equipment Total-Net | 949.17 | 922.09 | 955.39 |
| Total Current Liabilities | 1,897.5 | 1,089.1 | 1,452.12 |
| Total Inventory | 14.01 | 10.78 | 8.39 |
| Accounts Payable | 246.4 | 214.5 | 259.3 |
| Other Currentliabilities Total | 421.88 | 61.17 | 453.75 |
| Total Long Term Debt | 381.11 | 1,023.47 | 2,136.05 |
| Intangibles Net | 2,040.69 | 2,036.23 | 2,007.85 |
| Other Long Term Assets Total | 254.99 | 223.93 | 257.07 |
| Note Receivable-Long Term | 6.54 | 3.95 | 9.75 |
| Total Current Assets | 2,944.54 | 1,820.77 | 1,719.92 |
| Capital Lease Obligations | 381.11 | 456.43 | 471.35 |
| Long Term Investments | Not available | 4.67 | 4.63 |
Fundamentals
Valuation and ratios
Valuation
PEG Ratio0.24
Price to Sale Ratio2.85
Margins
Operating Margin 12m17.12
Net Profit Margin 12m13.04
Yield
Dividend Yield %0.34
Risk and consensus
Source-qualified signals
Risk metrics
Overall RiskBalanced risk
Board Risk38.32
Analyst consensus
ConsensusStrong Buy
Consensus score1.17
Analyst opinions6
Strong Sell count0
Sell count0
Hold count0
Buy count1
Strong Buy count5
Provider consensus uses a 1 (Strong Buy) to 5 (Strong Sell) score. The payload does not include price targets, so none are inferred from 52-week prices or recommendation percentages.Industry context
Peer comparison
Only peers present in the company profile payload are displayed.
| Company | Price | Market cap | P/E | Research |
|---|---|---|---|---|
| Delhivery | INR 469.9 | 35,198.08 | 226.01 | — |
| Urban Company | INR 142.5 | 22,053.45 | Not available | — |
| Indegene | INR 551 | 13,182.68 | 29.47 | — |
| BLS International Services | INR 253.8 | 10,449.98 | 14.15 | — |
| Axiscades Technologies | INR 1,631.95 | 6,917.58 | 83.28 | — |
Shareholding
Ownership
- Promoter
- 50.95%
- FII
- 9.99%
- MF
- 13.45%
- Other
- 25.61%
Company intelligence
Latest relevant news
Source, timestamp and external destination are shown. Provider relevance scores are not available.
Stocks to buy for short term: Himadri Speciality, Sagility among 5 contra bets Ambareesh Baliga recommends buying nowMarket news · 7 Apr 2026, 5:52 pm
SEBI-registered market expert Ambareesh Baliga unveils five stock recommendations, including Shakti Pumps and Sagility, amid the ongoing US-Iran war. The stock picks are part of his contrarian investing strategy.
How stress in the US healthcare sector could be a booster dose for SagilityMarket news · 27 Mar 2026, 1:56 pm
Insurers are outsourcing more work to specialised companies. According to Sagility management, this outsourcing market is growing steadily and there is still a lot of room to grow
Buy or sell: Vaishali Parekh recommends three stocks to buy today — 4 March 2026Market news · 4 Mar 2026, 9:10 am
Buy or sell: Vaishali Parekh recommends three stocks to buy today — Anand Rathi Wealth, Sagility India, and Crompton Greaves
Stocks to buy under <span class='webrupee'>₹</span>100: Sumeet Bagadia recommends three shares to buy or sell on Monday — 19 January 2026Market news · 18 Jan 2026, 12:59 pm
Stocks to buy under ₹ 100: Sumeet Bagadia recommends three shares to buy on Monday — Yes Bank, Sagility, and HFCL
Stocks to buy under <span class='webrupee'>₹</span>100: Sumeet Bagadia recommends three stocks to buy on Monday - 29 December 2025Market news · 28 Dec 2025, 11:43 am
Sumeet Bagadia has recommended three stocks to buy on Monday, December 29. The three stock picks by Bagadia are - MMTC, Hardwyn India, and Sagility.
Health-tech shines as India’s $283-billion IT sector battles slowing demandMarket news · 8 Dec 2025, 6:00 am
The health-tech sector in India, led by companies such as Sagility and Indegene, has demonstrated resilience, achieving higher revenue increases compared to traditional IT firms. This success is driven by adaptations to US healthcare regulations and a shift towards digital solutions.
Corporate actions
Events
- annual General MeetingAGM
- dividendRs.0.1000 per share(1%)Final Dividend
- board MeetingsQuarterly Results
- annual General MeetingPOM
- board MeetingsAudited Results, Final Dividend & ESOP
- board MeetingsQuarterly Results
- dividendRs.0.0500 per share(0.5%)Interim Dividend
- board MeetingsQuarterly Results & Interim Dividend
ShareKeyX Community
Discussion and sentiment for Sagility
Posts are linked to the canonical company record. Community BUY, NEUTRAL and SELL opinions are user-generated, moderated and separate from analyst consensus and ShareKeyX AI.
Checking your ShareKeyX account…
Company profile
Business information
What the company does
Sagility Ltd, formerly Sagility India Limited, is a provider of technology-enabled business solutions and services to clients in the United States healthcare industry. Its clients include payers (United States health insurance companies, which finance and reimburse the cost of health services) and providers (primarily hospitals, physicians, and diagnostic and medical devices companies). Its services to payers cater to various aspects of their operations, including core benefits administration functions such as claims management, enrollment and benefits plan building, and clinical functions such as utilization management and care management. Its services to providers include revenue cycle management functions such as financial clearance, medical coding, billing, and accounts receivable follow-up services. It also provides some of the services that it provides to Payers to pharmacy benefit managers that manage prescription drugs for members (insured persons) under health insurance plans.
Company facts
- Industry
- Business Services
- Sector
- Business Services
- NSE Code
- SAGILITY
- BSE Code
- 544282
Questions
Stock FAQ
What is the symbol and ISIN of Sagility?
Sagility has the symbol SAGILITY and ISIN - INE0W2G01015.
What is the current price of Sagility?
Sagility is currently trading at INR 42.56.
What are the year high and year low of Sagility?
Sagility has a year high of INR 57.89 and a year low of INR 35.83.
What is the market capitalization of Sagility?
Sagility has a market capitalization of INR 20,494.92 crore.
What is the P/E ratio of Sagility?
Sagility has a P/E ratio of 18.62.
What is the dividend yield of Sagility?
Sagility has a dividend yield of 0.34%.
How is the financial performance of Sagility based on revenue, net income, and EPS?
Sagility has revenue of INR 7,192.85 crore, net income of INR 924.77 crore, and EPS of INR 2.20.
What is the book value of Sagility?
Sagility has a book value of NA.
What is the debt-to-equity ratio of Sagility?
Sagility has a debt-to-equity ratio of NA.
What are the price-to-book and price-to-sales ratios of Sagility?
Sagility has a price-to-book ratio of NA and a price-to-sales ratio of 2.85.
Corporate-action adjustment is provider-defined. ShareKeyX research and computed indicators are not investment advice.